Charles Piwko

1.3k total citations
33 papers, 912 citations indexed

About

Charles Piwko is a scholar working on Molecular Biology, Epidemiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Charles Piwko has authored 33 papers receiving a total of 912 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Epidemiology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Charles Piwko's work include Neuroendocrine Tumor Research Advances (6 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Receptor Mechanisms and Signaling (6 papers). Charles Piwko is often cited by papers focused on Neuroendocrine Tumor Research Advances (6 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Receptor Mechanisms and Signaling (6 papers). Charles Piwko collaborates with scholars based in Canada, Switzerland and United States. Charles Piwko's co-authors include Thomas R. Einarson, Gideon Koren, Michaël Iskedjian, Basil G. Bereza, Daniël Hoyer, Allan Gordon, Wendy J. Ungar, Colin Vicente, Annamaria Vezzani and Caroline Maltepe and has published in prestigious journals such as Cancer Research, Neuroscience and Journal of Neurochemistry.

In The Last Decade

Charles Piwko

31 papers receiving 878 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles Piwko Canada 14 388 183 140 138 128 33 912
Sven Lyrenäs Sweden 17 317 0.8× 188 1.0× 123 0.9× 57 0.4× 39 0.3× 33 937
Kwanjin Park South Korea 20 106 0.3× 171 0.9× 48 0.3× 64 0.5× 113 0.9× 74 1.1k
A Mead United Kingdom 10 180 0.5× 54 0.3× 74 0.5× 41 0.3× 42 0.3× 18 1.0k
Richard C. Vari United States 18 133 0.3× 101 0.6× 119 0.8× 30 0.2× 177 1.4× 50 1.0k
Ramin Alemzadeh United States 28 268 0.7× 225 1.2× 40 0.3× 72 0.5× 59 0.5× 80 2.3k
Renate Savich United States 13 126 0.3× 416 2.3× 37 0.3× 53 0.4× 109 0.9× 33 747
Pamela Stitzlein Davies United States 12 184 0.5× 234 1.3× 86 0.6× 409 3.0× 45 0.4× 24 1.7k
Élisabeth Frauger France 21 616 1.6× 122 0.7× 60 0.4× 251 1.8× 94 0.7× 71 1.2k
Inge Gies Belgium 20 361 0.9× 207 1.1× 31 0.2× 379 2.7× 44 0.3× 70 1.7k
Hélène Leblanc France 15 95 0.2× 58 0.3× 69 0.5× 117 0.8× 74 0.6× 42 1.4k

Countries citing papers authored by Charles Piwko

Since Specialization
Citations

This map shows the geographic impact of Charles Piwko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Piwko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Piwko more than expected).

Fields of papers citing papers by Charles Piwko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Piwko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Piwko. The network helps show where Charles Piwko may publish in the future.

Co-authorship network of co-authors of Charles Piwko

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Piwko. A scholar is included among the top collaborators of Charles Piwko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Piwko. Charles Piwko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gentile, Pietro, Charles Piwko, Michael L. Markel, et al.. (2023). Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A systematic review and continuous Bayesian network meta-analysis. Frontiers in Medicine. 9. 998623–998623. 13 indexed citations
2.
Fiebig, Klaus M., et al.. (2021). Safety and efficacy of ALRV5XR in men with androgenetic alopecia: A randomised, double-blinded, placebo-controlled clinical trial. EClinicalMedicine. 40. 101124–101124. 8 indexed citations
3.
4.
Vicente, Colin, et al.. (2013). Cost-Utility Analysis Of Tocilizumab In The Treatment Of Active Systemic Juvenile Idiopathic Arthritis. Value in Health. 16(3). A225–A225. 1 indexed citations
5.
Einarson, Thomas R., et al.. (2013). Cost-effectiveness analysis of atypical long-acting antipsychotics for treating chronic schizophrenia in Finland. Journal of Medical Economics. 16(9). 1096–1105. 13 indexed citations
6.
7.
Einarson, Thomas R., et al.. (2012). Pharmacoeconomic analysis of paliperidone palmitate versus olanzapine pamoate for chronic schizophrenia in Norway. Acta Neuropsychiatrica. 25(2). 85–94. 16 indexed citations
8.
Einarson, Thomas R., et al.. (2012). Pharmacoeconomic analysis of paliperidone palmitate for treating schizophrenia in Greece. Annals of General Psychiatry. 11(1). 18–18. 23 indexed citations
9.
Einarson, Thomas R., et al.. (2011). PMH35 A Cost-Effectiveness Analysis of Paliperidone Palmitate Versus Olanzapine Pamoate in the Treatment of Schizophrenia in Norway. Value in Health. 14(7). A292–A293. 1 indexed citations
10.
Piwko, Charles, Colin Vicente, E Appel, et al.. (2011). The STARRT trial: a cost comparison of optimal vs sub-optimal initiation of dialysis in Canada. Journal of Medical Economics. 15(1). 96–104. 10 indexed citations
11.
Piwko, Charles, Olivier Desjardins, Basil G. Bereza, et al.. (2007). Pain Due to Multiple Sclerosis: Analysis of the Prevalence and Economic Burden in Canada. Pain Research and Management. 12(4). 259–265. 19 indexed citations
12.
Iskedjian, Michaël, Basil G. Bereza, Allan Gordon, Charles Piwko, & Thomas R. Einarson. (2006). Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain. Current Medical Research and Opinion. 23(1). 17–24. 146 indexed citations
13.
Koren, Gideon, Charles Piwko, Eric S. Ahn, et al.. (2005). Validation studies of the Pregnancy Unique-Quantification of Emesis (PUQE) scores. Journal of Obstetrics and Gynaecology. 25(3). 241–244. 97 indexed citations
14.
Piwko, Charles, Arielle Lasry, Khaled Alanezi, Peter C. Coyte, & Wendy J. Ungar. (2005). Economic evaluation of ondansetron vs dimenhydrinate for prevention of postoperative vomiting in children undergoing strabismus surgery. Pediatric Anesthesia. 15(9). 755–761. 7 indexed citations
15.
Iskedjian, Michaël, Charles Piwko, Neil H. Shear, Richard G. Langley, & Thomas R. Einarson. (2004). Topical Calcineurin Inhibitors in the Treatment of Atopic Dermatitis. American Journal of Clinical Dermatology. 5(4). 267–279. 19 indexed citations
16.
Piwko, Charles, et al.. (1997). The Elusive Nature of Cerebellar Somatostatin Receptors: Studies in Rat, Monkey and Human Cerebellum. Journal of Receptors and Signal Transduction. 17(1-3). 385–405. 11 indexed citations
17.
Piwko, Charles, et al.. (1997). Autoradiographic analysis of somatostatin SRIF1 and SRIF2 receptors in the human brain and pituitary. Naunyn-Schmiedeberg s Archives of Pharmacology. 355(2). 168–176. 12 indexed citations
18.
Piwko, Charles, et al.. (1997). Pharmacological characterisation of human cerebral cortex somatostatin SRIF1 and SRIF2 receptors. Naunyn-Schmiedeberg s Archives of Pharmacology. 355(2). 161–167. 14 indexed citations
19.
Piwko, Charles, et al.. (1996). Localization and pharmacological characterization of somatostatin recognition sites in the human cerebellum. Neuropharmacology. 35(6). 713–723. 11 indexed citations
20.
Piwko, Charles, et al.. (1995). Localization and pharmacological characterization of somatostatin sst2 sites in the rat cerebellum. Naunyn-Schmiedeberg s Archives of Pharmacology. 352(6). 607–13. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sven Lyrenäs Breakdown of academic impact, for papers by Kwanjin Park Breakdown of academic impact, for papers by A Mead Breakdown of academic impact, for papers by Richard C. Vari Breakdown of academic impact, for papers by Ramin Alemzadeh Breakdown of academic impact, for papers by Renate Savich Breakdown of academic impact, for papers by Pamela Stitzlein Davies Breakdown of academic impact, for papers by Élisabeth Frauger Breakdown of academic impact, for papers by Inge Gies Breakdown of academic impact, for papers by Hélène Leblanc
Rankless by CCL
2026